USANA Health Sciences, Inc.
USNA
$29.50
-$0.52-1.73%
NYSE
| 03/29/2025 | 12/28/2024 | 09/28/2024 | 06/29/2024 | 03/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 9.40M | 4.45M | 10.61M | 10.43M | 16.54M |
| Total Depreciation and Amortization | 10.25M | 5.88M | 5.56M | 5.70M | 5.08M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 5.33M | 948.00K | 4.77M | -3.54M | 7.56M |
| Change in Net Operating Assets | -9.50M | -5.50M | 8.59M | -4.60M | -11.49M |
| Cash from Operations | 15.48M | 5.79M | 29.53M | 7.99M | 17.68M |
| Capital Expenditure | -2.80M | -1.80M | -2.40M | -2.67M | -3.20M |
| Sale of Property, Plant, and Equipment | -- | 0.00 | 61.00K | 0.00 | 3.00K |
| Cash Acquisitions | -- | -203.34M | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -1.07M | 0.00 | 0.00 | 1.13M | -870.00K |
| Cash from Investing | -3.88M | -205.14M | -2.34M | -1.55M | -4.07M |
| Total Debt Issued | -- | 23.00M | -2.00K | 154.00K | 537.00K |
| Total Debt Repaid | -- | 6.00K | 3.00K | -1.48M | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -14.47M | -74.00K | -79.00K | -31.00K | -12.48M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -14.47M | 22.93M | -78.00K | -1.35M | -11.95M |
| Foreign Exchange rate Adjustments | 719.00K | -6.81M | 5.45M | -1.02M | -3.81M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -2.14M | -183.23M | 32.57M | 4.07M | -2.14M |